Actively Recruiting
Neurosensorial Disorder and Pain in Oral Cavity and Oropharynx Cancer Traited Patients (OCAPA)
Led by University Hospital, Clermont-Ferrand · Updated on 2025-09-02
120
Participants Needed
1
Research Sites
413 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Following preliminary studies carried out in our department on these subject and subjective findings during clinical examinations, it has been shown that pain is a symptom that is rarely reported following treatment. Instead, neurosensory disorders such as hypoesthesia and paresthesia are found. The objective of the study is to map and qualitatively evaluate neurosensory disorders in patients treated for cancers of the oral cavity and oropharynx.
CONDITIONS
Official Title
Neurosensorial Disorder and Pain in Oral Cavity and Oropharynx Cancer Traited Patients (OCAPA)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient treated for an oral cavity and oropharynx tumor at least one year and up to five years ago
- Men or women aged 18 years or older
- Patient who has given full informed consent
- Patient covered by the French social security system
You will not qualify if you...
- Patient with mental or psychological disorders or comprehension difficulties preventing full agreement to the protocol
- Pregnant or nursing women
- Patients unable to comply with the study protocol
- Refusal to participate
- Patients under legal protection or without full age
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU de Clermont-Ferrand
Clermont-Ferrand, France, 63000
Actively Recruiting
Research Team
L
Lise LACLAUTRE
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here